Have You Heard The Lawsuit That Links Abilify With Compulsive Gambling Problems & Spending? Just about every prescription drug on the market today comes with an extensive list of warnings. If a recent lawsuit filed in Nevada goes the plaintiff’s way, Abilify may have to add a stronger signal to its label; can cause compulsive gambling. According to a report on Drug Watch, five individuals in Nevada are pursuing a lawsuit against companies manufacturing and distributing the prescription drug Abilify. The primary claim of this lawsuit is this drug causes compulsive gambling. They are seeking damages against these companies because this is not listed as one of the drug’s side effects.
Does The Lawsuit Linking Abilify with Gambling Problems Have Legal Standing?
Otsuka Pharmaceutical Co Is In Washoe County District Court?
According to this report, the complaint was filed in Washoe County District Court last Wednesday. It names Japanese drug developer Otsuka Pharmaceutical Co. and its American business partner Bristol-Myers Squibb as the two chief companies in the lawsuit. It is also suing two sales representatives, who were also named in the suit.
Is The Side Effect Really Compulsive Gambling?
The main claim is that this side effect (compulsive gambling) was not communicated to both doctors and patients. It goes on to state that everyone named in this suit had ‘both the opportunity and the responsibility to do so.’
European Medicines Agencies Made This Claim Years Ago
Abilify is normally prescribed to treat bipolar disorders, schizophrenia, autism spectrum disorders and depression. According two PlaySlots4RealMoney, as early as 2011 the drug began to be linked to compulsive behavior. There was a report in the European Medicines Agencies that claimed there was a link between Abilify and compulsive gambling to the point where it “could not be excluded.”
New Information Added To The Abilify Label in Europe and Canada in 2012
The warning label on the drug eluded to the fact that compulsive gambling had been mentioned as a possible side effect. This new information was added to the Abilify label in Europe and Canada in 2012. However, the first time that this possible side effect started appearing on the label in the United States was in 2016. The report states that the US Food and Drug Administration (FDA) ordered manufacturers to add it to the label. Also, this was after a wave of reports of impulse control disorders started to mount.
30 Separate Reports Of Real Money Compulsive Gambling?
The lawsuit alleges that the delays in the label change are the crux of the issue. Before the FDA ruling, as many 30 separate reports of compulsive gambling surfaced from people using this drug. Most of the patients did not show any signs of compulsive behavior before Abilify was prescribed. It also states that these gambling urges did subside a bit after their dosages were adjusted downward to a lower level.
✓ Articles That May Interest You ·
Attorney Says Social Security checks Are spent Playing Slot Machines?
The lawyer representing the plaintiffs, in this case, is Peter Wetherall. His primary stance is that combination of Abilify with easy access to Nevada casinos and more specifically Las Vegas casinos are a dangerous combination. He was quoted in the Las Vegas Review-Journals as stating, “These people were vulnerable, to begin with, and things got much worse for them. Their meager little Social Security check is now being spent on a slot machine or whatever, so it’s pretty sad.” According to RXInjuryHelp.com, there are now close to 640 lawsuits for this drug as it pertains to compulsive gambling issues.